Missed the Congress ? NO Problem

Register to Watch Talks Replays
Immunotherapeutics 2023 | EUSTM Virtual Congress
Prof. Adam E. Snook

GUCY2C-directed vaccines for GI cancer recurrence prevention

A Talk by Prof. Adam E. Snook (Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA)

Proudly supported by

Junshi Biosciences
Hemosure
Incyte

About this Talk

The Speaker is updating the description for this Talk. Please check back here later.
Immunobiology Solid Tumors GI Tumors

06 May 2023, 09:00 AM

09:00 AM - 10:00 AM

About The Speaker

Prof. Adam E. Snook

Prof. Adam E. Snook

Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA

Junshi Biosciences

Founded in December 2012, Junshi Biosciences (HKEX: 1877; SSE: 688180) is an innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapeutics.

Main Sponsor

Hemosure

We at Hemosure are proud to manufacture and sell the fastest-growing Immunological Fecal Immunochemical Test (FIT) and have established its place as an industry leader.

Main Sponsor

Incyte

Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.

Main Sponsor

Want to sponsor this event? Contact Us

Ready to learn from the best?

Book your place now

Book my place